Parisian Family Office, CEO. Started Wall Street, '82. Drexel Burnham alum. Founded Chippewa Partners, Native American Advisors, '95. Chippewa, raised on reservations. Conservative. NYSE/FINRA arb. Pureblood. Independent insight. Trading WON/CANSLIM methodology from PAMELOT, TN farm, GHOST RANCH, MT, on Yellowstone River, or CASA TULE', their winter camp in Los Cabos, Mexico. Always been, will always be, a relentless optimist with radical gratitude.
Monday, October 01, 2007
Hythiam.............
Hythiam says investigators observe significant reduction in methamphetamine cravings and use in study of component of it's PROMETA treatment program published in Mayo Clinic Proceedings Journal. Hythiam announced that the Mayo Clinic Proceedings medical journal published in their October installment, an open-label study by Dr. Harold C. Urschel, III, M.D., M.M.A. of the pharmacological component of the PROMETA Treatment Program for methamphetamine dependence. The study found that this component of the PROMETA Treatment Program persistently reduced methamphetamine cravings and use.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment